"Located in the retirement community of Sun City, Arizona and serving the Sun Cities, Surprise, Peoria, and surrounding areas, the Banner Sun Health Research Institute conducts research, clinical care, prevention and education in both memory and movement disorders. Since its founding in 1986, the work by our scientists and physicians has had a significant impact on generating ground-breaking research in these debilitating age-related diseases."

During the past decade, Banner Sun Health Research Institute conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 30 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 19 clinical trials were completed. i.e. 82.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Banner Sun Health Research Institute" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "Biogen" with 5 trials sponsored, "University of Southern California" with 5 trials sponsored and "Eisai Inc." with 5 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Banner Sun Health Research Institute" #1 collaborator was "National Institute on Aging (NIA)" with 16 trials as a collaborator, "Alzheimer's Therapeutic Research Institute" with 8 trials as a collaborator, "Alzheimer's Disease Cooperative Study (ADCS)" with 4 trials as a collaborator, "Northern California Institute of Research and Education" with 4 trials as a collaborator and "Pfizer" with 4 trials as a collaborator. Other collaborators include 47 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Banner Sun Health Research Institute" are "Alzheimer's Disease" (30 trials), "Alzheimer Disease" (24 trials), "Parkinson Disease" (9 trials), "Mild Cognitive Impairment" (6 trials) and "Dementia" (5 trials). Many other conditions were trialed in "Banner Sun Health Research Institute" in a lesser frequency.

Most popular intervention types in "Banner Sun Health Research Institute" are "Drug" (73 trials), "Other" (4 trials), "Biological" (3 trials), "Procedure" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "Gantenerumab" (5 trials), "Placebo Control" (3 trials), "Solanezumab" (3 trials) and "ATH-1017" (2 trials). Other intervention names were less common.

The vast majority of trials in "Banner Sun Health Research Institute" are 88 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Banner Sun Health Research Institute". undefined are not yet recruiting, 13 are recruiting, 7 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 45 completed trials in Banner Sun Health Research Institute, 1 suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Banner Sun Health Research Institute, 0 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".